Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Geographic evidence hub

Netherlands research

Published infectious-disease research classified with a high-confidence geographic relationship to Netherlands.

Published evidence
17
Diseases
16
Countries
21
Topics
11

Evidence stream

Published literature

17

17 publications

Peer reviewedOpen accessSARSCOVID-19Vaccination
DOI 10.1016/j.vaccine.2026.129030 ↗

Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands

Anne J. Huiberts, Dirk Eggink, Brechje de Gier +7 more

Vaccine

Type
Cohort study
Scope
Netherlands

Why it matters nowThe findings indicate that JN.1 vaccination provided limited additional protection against SARS-CoV-2 infection during a low-incidence period, with modest effectiveness observed in both age groups. The results contribute to understanding the real-world performance of updated COVID-19 vaccines against emerging subvariants.

Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2 — Worldwide, November 2024–February 2026

Mila Shakya, Kevin C. Ma, Laura J. Hughes +20 more

MMWR. Morbidity and Mortality Weekly Report

Type
Journal article
Scope
United States, Netherlands, South Africa

Why it matters nowPersistent monitoring remains necessary to evaluate whether genetic shifts could diminish immunity from past exposures or shots, especially considering the ongoing global disease burden.

Peer reviewedOpen accessSmallpoxMonkeypoxVaccination
DOI 10.1016/s1473-3099(25)00545-6 ↗

Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study

Christophe Van Dijck, Nicole Berens-Riha, Luca M Zaeck +38 more

The Lancet Infectious Diseases

Type
Cohort study
Scope
Belgium, Netherlands

Why it matters nowThe observed differences in immune durability between natural infection and vaccination highlight potential considerations for maintaining population-level protection against circulating orthopoxviruses.

Identifying key weather factors influencing human salmonellosis: A conditional incidence analysis in England, Wales, and the Netherlands.

González Villeta LC, Chanamé Pinedo L, Cook AJC +10 more

The Journal of infection

Type
Journal article
Scope
Netherlands

Why it matters nowThe conditional incidence method offers a transparent and readily applicable tool for characterizing weather-disease relationships in different geographic settings and weather scenarios, which may inform public health planning for salmonellosis prevention and control.

Cross-sectoral genomic surveillance reveals a lack of insight in sources of human infections with Shiga toxin-producing Escherichia coli, the Netherlands, 2017 to 2023

Ingrid HM Friesema, Menno van der Voort, Ben Wit +4 more

Eurosurveillance

Type
Genomic study
Scope
Netherlands

Why it matters nowThe findings highlight gaps in identifying sources of human STEC infections despite existing monitoring programs. The decision to begin national-level STEC isolation aims to improve surveillance, source attribution, and guidance for monitoring and outbreak investigation.

Estimating the risk and spatial spread of measles in populations with high MMR uptake: Using school-household networks to understand the 2013 to 2014 outbreak in the Netherlands

James D. Munday, Katherine E. Atkins, Don Klinkenberg +5 more

PLOS Medicine

Type
Guideline
Scope
Netherlands, Myanmar

Why it matters nowClustering of unvaccinated children across primary and connected secondary schools can sustain sizable measles outbreaks even where national coverage exceeds 95%, suggesting that school-network structure is relevant for outbreak preparedness and response.

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023

Leanne PM van Leeuwen, Marc C Shamier, Babs E Verstrepen +11 more

Eurosurveillance

Type
Journal article
Scope
Netherlands

Why it matters nowThe findings indicate that antibody responses to MVA-BN vaccination may not persist beyond one year, highlighting the need for ongoing surveillance to assess the public health implications of declining antibody levels for mpox outbreak preparedness.

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022

Brechje de Gier, Liselotte van Asten, Tjarda M. Boere +9 more

Vaccine

Type
Journal article
Scope
Netherlands

Why it matters nowThe findings demonstrate substantial population-level reduction in COVID-19 mortality through vaccination with no observed increase in non-COVID-19 mortality, providing evidence for the safety and effectiveness of COVID-19 vaccination programs.

Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine

Catharina E van Ewijk, Fuminari Miura, Gini van Rijckevorsel +18 more

Eurosurveillance

Type
Journal article
Scope
Netherlands

Why it matters nowThe findings characterize a high-incidence mpox outbreak in a specific population and provide quantitative estimates of vaccine protection, contributing evidence relevant to vaccination strategy and risk communication for at-risk communities.

VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment

Jon Salmanton-García, Fiona A. Stewart, Sarah Heringer +48 more

Vaccine

Type
Journal article
Scope
Austria, Belgium, Cyprus

Why it matters nowThe registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.

Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis

Frank G. Sandmann, Edwin van Leeuwen, Sibylle Bernard-Stoecklin +21 more

Vaccine

Type
Mathematical modelling
Scope
Spain, France, Ireland

Why it matters nowDespite existing vaccination programs targeting older adults and high-risk groups, substantial influenza burden persists in Europe. The findings suggest that combined strategies using improved vaccines for the elderly and universal pediatric vaccination may offer direct and indirect protection that is cost-effective across diverse European settings, supporting broader policy considerations for seasonal influenza control.

Dot map cartograms for detection of infectious disease outbreaks: an application to Q fever, the Netherlands and pertussis, Germany

Loes Soetens, Susan Hahné, Jacco Wallinga

Eurosurveillance

Type
Journal article
Scope
Germany, Netherlands

Why it matters nowDot map cartograms may support outbreak detection and visualization by public health professionals, facilitating informed decisions for investigation and control activities.

Modelling the risk of transfusion transmission from travelling donors

Tonderai Mapako, Welling Oei, Marinus van Hulst +2 more

BMC Infectious Diseases

Type
Journal article
Scope
Italy, Netherlands

Why it matters nowThe model provides decision-makers with quantitative estimates of past versus future transfusion transmission risk from traveling donors, supporting evidence-based decisions about public communication and blood safety interventions during emerging disease outbreaks.

Peer reviewedOpen accessHaemophilus influenzaeSurveillanceVaccinationTreatment
DOI 10.1016/j.vaccine.2015.11.060 ↗

Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands

Astrid A.T.M. Bosch, Marlies A. van Houten, Jacob P. Bruin +5 more

Vaccine

Type
Journal article
Scope
Netherlands, United States

Why it matters nowThe findings suggest carriage surveillance can assess vaccine effects on circulating pathogens, evaluate pneumococcal conjugate vaccine impact, and predict changes in respiratory and invasive disease. A potential new equilibrium between non-vaccine pneumococcal serotypes and other pathogenic bacteria may be emerging in the post-PCV era.

Underdiagnosis of Foodborne Hepatitis A, the Netherlands, 2008–20101

Mariska Petrignani, Linda Verhoef, Harry Vennema +4 more

Emerging Infectious Diseases

Type
Journal article
Scope
Netherlands

Why it matters nowThe article is relevant to outbreak recognition and surveillance methods for hepatitis A, especially where routine systems may miss food-associated cases. It frames the work as important for understanding how a complex food market may affect detection outside endemic settings.

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

Marion Koopmans, Berry Wilbrink, Marina Conyn +8 more

The Lancet

Type
Outbreak investigation
Scope
Netherlands

Why it matters nowThe authors highlight the importance of adequate surveillance, outbreak preparedness, and pandemic planning, given the unexpectedly high number of zoonotic transmissions and evidence of person-to-person spread.

Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy

J DEJONG

Vaccine

Type
Genomic study
Scope
Belgium, Netherlands

Why it matters nowThe observed antigenic divergence between circulating swine H3N2 viruses and existing vaccine strains highlights the importance of matching veterinary vaccines to currently circulating strains to maintain effective protection in pig populations.